Global Continuous Glucose Monitoring Device Market by End Use (Homecare, Hospitals), by Component (Sensors, Transmitters) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028
Summary of the Report
Global continuous glucose monitoring device market was valued at USD4.7 billion in 2020. It is projected to grow at a compound annual rate (CAGR of 10.1%) between 2021 and 2028. This market is driven by rising diabetes incidence and the growing number of diabetics. The Continuous Glucose Monitor (CGM) market is further supported by increasing awareness about diabetes prevention, new product launches and supportive government initiatives. The COVID-19 pandemic has seen an increase in demand for continuous glucose monitoring devices. Federal agencies have released guidelines and loosening regulations for home-use glucose meters. Dexcom G6 is one of the approved CGMs for hospital use. Abbott FreeStyle Libre is another.
This was done primarily to protect healthcare workers and patients from self-testing. Many resources were also published by the American Diabetic Association on COVID-19, diabetes. These devices may not be adopted if there is delay in diagnosis, as lockdown restrictions and low awareness in several developing countries. Novartis AG's survey found that only 7% of people visit their doctors in an early stage or pre-diabetic condition. This leaves 93% of those with type 2 diabetes. The market's growth is due in part to an increase in diabetes incidence due to obesity, aging, and unhealthy lifestyles.
Impact of COVID19: High use in isolated patients. From 2019, the market grew by 18%.
|
Pandemic Impact |
Outlook after COVID |
|
The CGM has seen a sudden increase in demand during COVID-19 due to remote monitoring of COVID-19 patient. |
Research suggests that CGM users spent more time in the range of their CGM during the pandemic. These trends will have an impact on CGM adoption in the coming years. |
|
During the pandemic, there was a lot of demand for continuous monitoring of COVID-19 patients in both hospital and at home. |
COVID-19 patients with diabetes who have been treated for the disease develop resistance to insulin. Traditional insulin injections no longer work as they are not effective in managing their condition. CGM can replace frequent sugar level checks. |
Diabetes is often caused by obesity. WHO estimates that in 2016, more than 1.9 billion people were overweight. Of these, approximately 650 million were obese. These devices enable the monitoring of blood glucose over various time periods using a sensor. The readings are then transmitted via a wireless network. The patient's data is fed into the diabetes management software, which allows them to better understand their disease and help them manage it.
Component Insights
CGM devices can be divided into three broad categories according to their components: transmitters, receivers and sensors. In 2020, the highest revenue share was held by the sensors segment with 39%. This segment is expected to grow at 10.0% between 2021 and 2028. The most advanced part of CGM devices are sensors. They consist of a thin metallic filament that is inserted in the fat layer below the skin. Sensors use a slightly different technology than receivers and transmitters. These components use glucose oxidase to detect blood sugar levels.
The enzyme glucose oxidase converts glucose into hydrogen peroxidase. This reacts with the platinum in the sensor and produces an electrical signal that can be transmitted to the transmitter. The receiver and a transmitter work together to collect readings from the sensor. The transmitter displays the results on the monitor. The transmitter signals are received by a battery-powered receiver, which displays the results. This receiver can display various graphs and statistics, which can be used to customize medication. It is useful for people with hyperglycemic and hypoglycemic conditions.
End-use Insights
Globally, the home care segment accounted for more than 43% of the market's revenue in 2020. This segment will grow at the fastest rate of CAGR over the next few years. The market can be divided into three segments based on its end use: hospitals, home healthcare, and others. From 2021 to 2028, the hospital segment will grow at a second highest CAGR of 9.5%. This growth is due to increased use of CGM devices in hospitals, healthcare settings and for the detection of diabetes mellitus blood sugar levels.
According to the National Center for Biotechnology Information, CGM devices perform significantly better than Self-monitoring blood glucose (SMBG), devices in clinical trials involving gestational diabetic mellitus. The hospital end-use market will also benefit from the adoption of more technologically advanced devices to manage diabetes mellitus.
Regional Insights
North America was the largest regional market in 2020, accounting for 39% of all revenue. Due to the existence of a thriving healthcare sector, the regional market will continue to grow at a steady CAGR between 2021 and 2028. Regional market growth is expected to be driven by the increasing prevalence of obesity and the availability of effective reimbursement policies. There are also growing awareness about advanced technologies for diabetes management.
Asia Pacific, on the other hand is expected to be the fastest growing regional market between 2021 and 2028. Asia Pacific is home to a higher proportion of diabetics than other regions. According to the International Diabetes Federation (IDF), India and China have the highest number of diabetics in the world. Type I and II diabetes have been exacerbated by the rise in obesity and socio-economic changes.
Market Share Insights & Key Companies
A large number of international and regional companies are present in the market. The majority of leading companies are involved with strategic collaborations, product development, mergers and acquisitions and regional expansions in order to increase their revenue share.
Medtronic, for example, announced FDA approval in November 2020 for their smart insulin pen, "InPen", which is indicated for patients with diabetes who require multiple daily injections. Guardian CGM allows for real-time access and analysis of insulin and glucose levels. These are some of the major players in the global market for continuous glucose monitoring devices:
-
Medtronic
-
Dexcom, Inc.
-
F. Hoffmann-La Roche Ltd.
-
Abbott
-
Novo Nordisk A/S
-
Ypsomed
-
GlySens, Inc.
Up Market Research published a new report titled “Continuous Glucose Monitoring Device Market research report which is segmented by End Use (Homecare, Hospitals), by Component (Sensors, Transmitters), By Players/Companies Inc; Animas Corporation; Novo Nordisk; Ypsomed; and GlySens, Pfizer Inc; Baxter International Inc; Abbott Laboratories; Medtronic”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.
Report Scope
| Report Attributes | Report Details |
| Report Title | Continuous Glucose Monitoring Device Market Research Report |
| By End Use | Homecare, Hospitals |
| By Component | Sensors, Transmitters |
| By Companies | Inc; Animas Corporation; Novo Nordisk; Ypsomed; and GlySens, Pfizer Inc; Baxter International Inc; Abbott Laboratories; Medtronic |
| Regions Covered | North America, Europe, APAC, Latin America, MEA |
| Base Year | 2020 |
| Historical Year | 2018 to 2019 (Data from 2010 can be provided as per availability) |
| Forecast Year | 2028 |
| Number of Pages | 224 |
| Number of Tables & Figures | 157 |
| Customization Available | Yes, the report can be customized as per your need. |
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
Global Continuous Glucose Monitoring Device Market Report Segments:
The market is segmented by End Use (Homecare, Hospitals), by Component (Sensors, Transmitters).
Continuous Glucose Monitoring Device Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Continuous Glucose Monitoring Device Market
Overview of the regional outlook of the Continuous Glucose Monitoring Device Market:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
Highlights of The Continuous Glucose Monitoring Device Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of Continuous Glucose Monitoring Device Market.
- Historical data and forecast.
- Estimations for the forecast period 2028.
- Developments and trends in the market.
1. Homecare
2. Hospitals
7. By Component:1. Sensors
2. Transmitters
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Continuous Glucose Monitoring Device Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
Reasons to Purchase the Continuous Glucose Monitoring Device Market Report:
- The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
- Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
- Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
- The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
- Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Continuous Glucose Monitoring Device Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Continuous Glucose Monitoring Device Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Continuous Glucose Monitoring Device Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Continuous Glucose Monitoring Device Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Continuous Glucose Monitoring Device Market Size & Forecast, 2018-2028
4.5.1 Continuous Glucose Monitoring Device Market Size and Y-o-Y Growth
4.5.2 Continuous Glucose Monitoring Device Market Absolute $ Opportunity
Chapter 5 Global Continuous Glucose Monitoring Device Market Analysis and Forecast by End Use
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by End Use
5.1.2 Basis Point Share (BPS) Analysis by End Use
5.1.3 Absolute $ Opportunity Assessment by End Use
5.2 Continuous Glucose Monitoring Device Market Size Forecast by End Use
5.2.1 Homecare
5.2.2 Hospitals
5.3 Market Attractiveness Analysis by End Use
Chapter 6 Global Continuous Glucose Monitoring Device Market Analysis and Forecast by Component
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Component
6.1.2 Basis Point Share (BPS) Analysis by Component
6.1.3 Absolute $ Opportunity Assessment by Component
6.2 Continuous Glucose Monitoring Device Market Size Forecast by Component
6.2.1 Sensors
6.2.2 Transmitters
6.3 Market Attractiveness Analysis by Component
Chapter 7 Global Continuous Glucose Monitoring Device Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Continuous Glucose Monitoring Device Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Continuous Glucose Monitoring Device Analysis and Forecast
9.1 Introduction
9.2 North America Continuous Glucose Monitoring Device Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Continuous Glucose Monitoring Device Market Size Forecast by End Use
9.6.1 Homecare
9.6.2 Hospitals
9.7 Basis Point Share (BPS) Analysis by End Use
9.8 Absolute $ Opportunity Assessment by End Use
9.9 Market Attractiveness Analysis by End Use
9.10 North America Continuous Glucose Monitoring Device Market Size Forecast by Component
9.10.1 Sensors
9.10.2 Transmitters
9.11 Basis Point Share (BPS) Analysis by Component
9.12 Absolute $ Opportunity Assessment by Component
9.13 Market Attractiveness Analysis by Component
Chapter 10 Europe Continuous Glucose Monitoring Device Analysis and Forecast
10.1 Introduction
10.2 Europe Continuous Glucose Monitoring Device Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Continuous Glucose Monitoring Device Market Size Forecast by End Use
10.6.1 Homecare
10.6.2 Hospitals
10.7 Basis Point Share (BPS) Analysis by End Use
10.8 Absolute $ Opportunity Assessment by End Use
10.9 Market Attractiveness Analysis by End Use
10.10 Europe Continuous Glucose Monitoring Device Market Size Forecast by Component
10.10.1 Sensors
10.10.2 Transmitters
10.11 Basis Point Share (BPS) Analysis by Component
10.12 Absolute $ Opportunity Assessment by Component
10.13 Market Attractiveness Analysis by Component
Chapter 11 Asia Pacific Continuous Glucose Monitoring Device Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Continuous Glucose Monitoring Device Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Continuous Glucose Monitoring Device Market Size Forecast by End Use
11.6.1 Homecare
11.6.2 Hospitals
11.7 Basis Point Share (BPS) Analysis by End Use
11.8 Absolute $ Opportunity Assessment by End Use
11.9 Market Attractiveness Analysis by End Use
11.10 Asia Pacific Continuous Glucose Monitoring Device Market Size Forecast by Component
11.10.1 Sensors
11.10.2 Transmitters
11.11 Basis Point Share (BPS) Analysis by Component
11.12 Absolute $ Opportunity Assessment by Component
11.13 Market Attractiveness Analysis by Component
Chapter 12 Latin America Continuous Glucose Monitoring Device Analysis and Forecast
12.1 Introduction
12.2 Latin America Continuous Glucose Monitoring Device Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Continuous Glucose Monitoring Device Market Size Forecast by End Use
12.6.1 Homecare
12.6.2 Hospitals
12.7 Basis Point Share (BPS) Analysis by End Use
12.8 Absolute $ Opportunity Assessment by End Use
12.9 Market Attractiveness Analysis by End Use
12.10 Latin America Continuous Glucose Monitoring Device Market Size Forecast by Component
12.10.1 Sensors
12.10.2 Transmitters
12.11 Basis Point Share (BPS) Analysis by Component
12.12 Absolute $ Opportunity Assessment by Component
12.13 Market Attractiveness Analysis by Component
Chapter 13 Middle East & Africa (MEA) Continuous Glucose Monitoring Device Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Continuous Glucose Monitoring Device Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Continuous Glucose Monitoring Device Market Size Forecast by End Use
13.6.1 Homecare
13.6.2 Hospitals
13.7 Basis Point Share (BPS) Analysis by End Use
13.8 Absolute $ Opportunity Assessment by End Use
13.9 Market Attractiveness Analysis by End Use
13.10 Middle East & Africa (MEA) Continuous Glucose Monitoring Device Market Size Forecast by Component
13.10.1 Sensors
13.10.2 Transmitters
13.11 Basis Point Share (BPS) Analysis by Component
13.12 Absolute $ Opportunity Assessment by Component
13.13 Market Attractiveness Analysis by Component
Chapter 14 Competition Landscape
14.1 Continuous Glucose Monitoring Device Market: Competitive Dashboard
14.2 Global Continuous Glucose Monitoring Device Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Inc; Animas Corporation; Novo Nordisk; Ypsomed; and GlySens
14.3.2 Pfizer Inc; Baxter International Inc; Abbott Laboratories; Medtronic
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Continuous Glucose Monitoring Device Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Continuous Glucose Monitoring Device Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Continuous Glucose Monitoring Device Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Continuous Glucose Monitoring Device Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Continuous Glucose Monitoring Device Market Size & Forecast, 2018-2028
4.5.1 Continuous Glucose Monitoring Device Market Size and Y-o-Y Growth
4.5.2 Continuous Glucose Monitoring Device Market Absolute $ Opportunity
Chapter 5 Global Continuous Glucose Monitoring Device Market Analysis and Forecast by End Use
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by End Use
5.1.2 Basis Point Share (BPS) Analysis by End Use
5.1.3 Absolute $ Opportunity Assessment by End Use
5.2 Continuous Glucose Monitoring Device Market Size Forecast by End Use
5.2.1 Homecare
5.2.2 Hospitals
5.3 Market Attractiveness Analysis by End Use
Chapter 6 Global Continuous Glucose Monitoring Device Market Analysis and Forecast by Component
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Component
6.1.2 Basis Point Share (BPS) Analysis by Component
6.1.3 Absolute $ Opportunity Assessment by Component
6.2 Continuous Glucose Monitoring Device Market Size Forecast by Component
6.2.1 Sensors
6.2.2 Transmitters
6.3 Market Attractiveness Analysis by Component
Chapter 7 Global Continuous Glucose Monitoring Device Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Continuous Glucose Monitoring Device Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Continuous Glucose Monitoring Device Analysis and Forecast
9.1 Introduction
9.2 North America Continuous Glucose Monitoring Device Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Continuous Glucose Monitoring Device Market Size Forecast by End Use
9.6.1 Homecare
9.6.2 Hospitals
9.7 Basis Point Share (BPS) Analysis by End Use
9.8 Absolute $ Opportunity Assessment by End Use
9.9 Market Attractiveness Analysis by End Use
9.10 North America Continuous Glucose Monitoring Device Market Size Forecast by Component
9.10.1 Sensors
9.10.2 Transmitters
9.11 Basis Point Share (BPS) Analysis by Component
9.12 Absolute $ Opportunity Assessment by Component
9.13 Market Attractiveness Analysis by Component
Chapter 10 Europe Continuous Glucose Monitoring Device Analysis and Forecast
10.1 Introduction
10.2 Europe Continuous Glucose Monitoring Device Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Continuous Glucose Monitoring Device Market Size Forecast by End Use
10.6.1 Homecare
10.6.2 Hospitals
10.7 Basis Point Share (BPS) Analysis by End Use
10.8 Absolute $ Opportunity Assessment by End Use
10.9 Market Attractiveness Analysis by End Use
10.10 Europe Continuous Glucose Monitoring Device Market Size Forecast by Component
10.10.1 Sensors
10.10.2 Transmitters
10.11 Basis Point Share (BPS) Analysis by Component
10.12 Absolute $ Opportunity Assessment by Component
10.13 Market Attractiveness Analysis by Component
Chapter 11 Asia Pacific Continuous Glucose Monitoring Device Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Continuous Glucose Monitoring Device Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Continuous Glucose Monitoring Device Market Size Forecast by End Use
11.6.1 Homecare
11.6.2 Hospitals
11.7 Basis Point Share (BPS) Analysis by End Use
11.8 Absolute $ Opportunity Assessment by End Use
11.9 Market Attractiveness Analysis by End Use
11.10 Asia Pacific Continuous Glucose Monitoring Device Market Size Forecast by Component
11.10.1 Sensors
11.10.2 Transmitters
11.11 Basis Point Share (BPS) Analysis by Component
11.12 Absolute $ Opportunity Assessment by Component
11.13 Market Attractiveness Analysis by Component
Chapter 12 Latin America Continuous Glucose Monitoring Device Analysis and Forecast
12.1 Introduction
12.2 Latin America Continuous Glucose Monitoring Device Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Continuous Glucose Monitoring Device Market Size Forecast by End Use
12.6.1 Homecare
12.6.2 Hospitals
12.7 Basis Point Share (BPS) Analysis by End Use
12.8 Absolute $ Opportunity Assessment by End Use
12.9 Market Attractiveness Analysis by End Use
12.10 Latin America Continuous Glucose Monitoring Device Market Size Forecast by Component
12.10.1 Sensors
12.10.2 Transmitters
12.11 Basis Point Share (BPS) Analysis by Component
12.12 Absolute $ Opportunity Assessment by Component
12.13 Market Attractiveness Analysis by Component
Chapter 13 Middle East & Africa (MEA) Continuous Glucose Monitoring Device Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Continuous Glucose Monitoring Device Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Continuous Glucose Monitoring Device Market Size Forecast by End Use
13.6.1 Homecare
13.6.2 Hospitals
13.7 Basis Point Share (BPS) Analysis by End Use
13.8 Absolute $ Opportunity Assessment by End Use
13.9 Market Attractiveness Analysis by End Use
13.10 Middle East & Africa (MEA) Continuous Glucose Monitoring Device Market Size Forecast by Component
13.10.1 Sensors
13.10.2 Transmitters
13.11 Basis Point Share (BPS) Analysis by Component
13.12 Absolute $ Opportunity Assessment by Component
13.13 Market Attractiveness Analysis by Component
Chapter 14 Competition Landscape
14.1 Continuous Glucose Monitoring Device Market: Competitive Dashboard
14.2 Global Continuous Glucose Monitoring Device Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Inc; Animas Corporation; Novo Nordisk; Ypsomed; and GlySens
14.3.2 Pfizer Inc; Baxter International Inc; Abbott Laboratories; Medtronic
Segments Covered in the Report
The global Continuous Glucose Monitoring Device market has been segmented based on
By End Use
The global Continuous Glucose Monitoring Device market has been segmented based on
By End Use
- Homecare
- Hospitals
- Sensors
- Transmitters
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
- Inc; Animas Corporation; Novo Nordisk; Ypsomed; and GlySens
- Pfizer Inc; Baxter International Inc; Abbott Laboratories; Medtronic
Our Clients
Related Reports
Some other reports from this category!
